[Clinical trial of Versapen in pneumophtisiology].
D000328:Adult; D000368:Aged; D001984:Bronchial Neoplasms / Q000150:complications; D001986:Bronchial Spasm / Q000150:complications; D001991:Bronchitis / Q000150:complications; D002908:Chronic Disease; D003371:Cough / Q000188:drug therapy; D005260:Female; D006801:Humans; D007093:Imidazoles / Q000627:therapeutic use; D008171:Lung Diseases / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D010406:Penicillins / Q000627:therapeutic use*; D010998:Pleurisy / Q000188:drug therapy; D012141:Respiratory Tract Infections / Q000188:drug therapy; D013844:Thiazoles / Q000627:therapeutic use*
D007093:Imidazoles; D010406:Penicillins; D013844:Thiazoles
L'expérimentation clinique du Versapen en pneumo-phtisiologie.